Stock Events

Stock Events

Ernexa Therapeutics (ERNAW) Q2 2026 Earnings

11MayConfirmed

Q1 2023

Q2 2025

Q2 2026

-900

-600.65

-301.3

-1.95

Details

Expected EPS

-1.95

Actual EPS

-6.95

Surprise EPS

-5

Surprise Percent

+256.41%

Description

Ernexa Therapeutics (ERNAW) has reported earnings of -6.95 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.